Ana María
Lorenzo Vizcaya
University College London
Londres, Reino UnidoPublications in collaboration with researchers from University College London (2)
2022
-
Clinical trials in systemic lupus erythematosus: The dilemma - Why have phase III trials failed to confirm the promising results of phase II trials?
Annals of the Rheumatic Diseases, Vol. 82, Núm. 2, pp. 169-174
2020
-
Bruton’s tyrosine kinase inhibitors: A new therapeutic target for the treatment of SLE?
ImmunoTargets and Therapy, Vol. 9, pp. 105-110